$IRWD SEC Filings

Filed On	Filing
16 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers – Tom McCourt to Retire from CEO Post After 17 Years at Ironwood and Four Decades of Distinguished Industry Leadership Bringing Transformational Medicines to Patients –
23 Sep 2026	144
17 Sep 2026	Form 4: Denner Alexander J, Director Received 3,694 shares as a grant or award
14 Aug 2026	SCHEDULE 13G/A
07 Aug 2026	SCHEDULE 13G
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	SCHEDULE 13G/A
22 Jul 2026	Form 4: Silber Jeffrey, SVP, CMO, Head-Res&Drug Received 137,036 shares as a grant or award
22 Jul 2026	Form 3: Silber Jeffrey, SVP, CMO, Head-Res&Drug No securities owned
09 Jul 2026	Form 4: Silver Ronald, PFO & PAO Sold 127,890 shares ($578K)
07 Jul 2026	144
18 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
17 Jun 2026	Form 4: Shepard Jay, Director Received 63,481 shares as a grant or award
17 Jun 2026	Form 4: Kessler Marla L, Director Received 63,481 shares as a grant or award
17 Jun 2026	Form 4: Currie Mark G, Director Received 63,481 shares as a grant or award
17 Jun 2026	Form 4: Duane Jon R, Director Received 63,481 shares as a grant or award
17 Jun 2026	Form 4: Denner Alexander J, Director Received 4,065 shares as a grant or award · Received 63,481 shares as a grant or award
17 Jun 2026	Form 4: McHugh Julie, Director Received 63,481 shares as a grant or award · Sold 21,571 shares ($80.5K)
17 Jun 2026	Form 4: Moukheibir Catherine, Director Received 63,481 shares as a grant or award

Comments